Cargando…
Pediococcus pentosaceus CECT 8330 protects DSS-induced colitis and regulates the intestinal microbiota and immune responses in mice
BACKGROUND: Compelling evidences demonstrated that gut microbiota dysbiosis plays a critical role in the pathogenesis of inflammatory bowel diseases (IBD). Therapies for targeting the microbiota may provide alternative options for the treatment of IBD, such as probiotics. Here, we aimed to investiga...
Autores principales: | Dong, Fang, Xiao, Fangfei, Li, Xiaolu, Li, Youran, Wang, Xufei, Yu, Guangjun, Zhang, Ting, Wang, Yizhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761308/ https://www.ncbi.nlm.nih.gov/pubmed/35033121 http://dx.doi.org/10.1186/s12967-022-03235-8 |
Ejemplares similares
-
Bifidobacterium longum CECT 7894 Improves the Efficacy of Infliximab for DSS-Induced Colitis via Regulating the Gut Microbiota and Bile Acid Metabolism
por: Xiao, Fangfei, et al.
Publicado: (2022) -
Infantile Colic Treated With Bifidobacterium longum CECT7894 and Pediococcus pentosaceus CECT8330: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Chen, Ke, et al.
Publicado: (2021) -
Pediococcus pentosaceus LI05 alleviates DSS‐induced colitis by modulating immunological profiles, the gut microbiota and short‐chain fatty acid levels in a mouse model
por: Bian, Xiaoyuan, et al.
Publicado: (2020) -
F. prausnitzii-derived extracellular vesicles attenuate experimental colitis by regulating intestinal homeostasis in mice
por: Ye, Lin, et al.
Publicado: (2023) -
Pediococcus pentosaceus, a future additive or probiotic candidate
por: Jiang, Shiman, et al.
Publicado: (2021)